EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine

Karin P S Langenberg, Sander R van Hooff, Bianca Koopmans, Josephine G M Strijker, Waleed M Kholosy, Kimberley Ober, Danny A Zwijnenburg, Jessica J F van der Hoek, Kaylee M Keller, Lindy Vernooij, Linda G Schild, Eleonora J Looze und 27 weitere

European Journal of Cancer · 2025-03 · 218 · 115275

DOI: 10.1016/j.ejca.2025.115275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2025-03. Verfasst von Karin P S Langenberg und 38 weiteren Autor:innen. Beteiligte Einrichtung: Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: k.p.s.langenberg@prinsesmaxim…. Hauptthemen laut MEDLINE: Neuroblastoma, Precision Medicine, Organoids, High-Throughput Screening Assays. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Krebshilfe, Deutsches Krebsforschungszentrum, Bundesministerium für Gesundheit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaPrecision MedicineOrganoidsHigh-Throughput Screening AssaysAntineoplastic AgentsHumansCell Line, TumorDrug Screening Assays, AntitumorTranscriptomeGene Expression Profiling

Stichwörter der Autor:innen

AdolescentCancerChildHigh-throughput drug screeningMolecular biologyMolecular targeted therapyNeuroblastomaNext-generation sequencingOrganoidPrecision medicine

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: k.p.s.langenberg@prinsesmaximacentrum.nl.
  • Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: s.r.vanhooff-3@prinsesmaximacentrum.nl.
  • Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: B.Koopmans@prinsesmaximacentrum.nl.
  • Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: J.G.M.Strijker@prinsesmaximacentrum.nl.
  • Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: w.kholosy@amsterdamumc.nl.
  • Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: k.ober@erasmusmc.nl.

Förderung

  • Deutsche Krebshilfe
  • Deutsches Krebsforschungszentrum
  • Bundesministerium für Gesundheit
  • HORIZON EUROPE European Research Council
  • Horizon 2020
  • Children Cancer Free Foundation
  • Bundesministerium für Bildung und Forschung
  • Deutschen Konsortium für Translationale Krebsforschung

Zitieren

APA

Langenberg, K. P. S., van Hooff, S. R., Koopmans, B., Strijker, J. G. M., Kholosy, W. M., Ober, K., Zwijnenburg, D. A., van der Hoek, J. J. F., Keller, K. M., Vernooij, L., Schild, L. G., Looze, E. J., Ebus, M. E., Essing, A. H. W., Vree, P., Tas, M. L., Matser, Y. A. H., Wienke, J., Volckmann, R., …, & Molenaar, J. J. (2025). Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine. European Journal of Cancer, 218, 115275. https://doi.org/10.1016/j.ejca.2025.115275

Vancouver

Langenberg KPS, van Hooff SR, Koopmans B, Strijker JGM, Kholosy WM, Ober K, et al. Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine. European Journal of Cancer. 2025;218:115275. doi:10.1016/j.ejca.2025.115275

BibTeX
@article{Langenberg2025,
  author = {Langenberg, Karin P S and van Hooff, Sander R and Koopmans, Bianca and Strijker, Josephine G M and Kholosy, Waleed M and Ober, Kimberley and Zwijnenburg, Danny A and van der Hoek, Jessica J F and Keller, Kaylee M and Vernooij, Lindy and Schild, Linda G and Looze, Eleonora J and Ebus, Marli E and Essing, Anke H W and Vree, Paula de and Tas, Michelle L and Matser, Yvette A H and Wienke, Judith and Volckmann, Richard and Tops, Bastiaan B J and Kester, Lennart A and Badloe, Shashi and Hehir-Kwa, Jayne Y and Kemmeren, Patrick and Goemans, Bianca F and Zwaan, C Michel and Oehme, Ina and Jäger, Nathalie and Witt, Olaf and van Eijkelenburg, Natasha K A and Dierselhuis, Miranda P and Tytgat, Godelieve A M and Wijnen, Marc H W and van Noesel, Max M and de Krijger, Ronald R and Eising, Selma and Koster, Jan and Dolman, Emmy M and Molenaar, Jan J},
  title = {Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine},
  journal = {European Journal of Cancer},
  year = {2025},
  volume = {218},
  pages = {115275},
  doi = {10.1016/j.ejca.2025.115275}
}
Kostenlos starten →